These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27014971)

  • 21. Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients.
    Zheng RR; Huang XX; Jin C; Zhuang XX; Ye LC; Zheng FY; Lin F
    Clin Chim Acta; 2017 Oct; 473():198-203. PubMed ID: 27836106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status.
    Jeong SY; Park H; Kim MS; Kang JH; Paik ES; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Cancer Res Treat; 2020 Apr; 52(2):516-523. PubMed ID: 31671937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
    Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
    Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.
    Gemer O; Eitan R; Gdalevich M; Mamanov A; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Ben Shachar I; Ben Arie A; Lavie O
    Eur J Surg Oncol; 2013 Jan; 39(1):76-80. PubMed ID: 23131429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.
    Roman LD; Felix JC; Muderspach LI; Varkey T; Burnett AF; Qian D; Morrow CP
    Gynecol Oncol; 1998 Mar; 68(3):220-5. PubMed ID: 9570969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy.
    Lv Y; Wang N; Liu Y; Li X; Fan L; Li M; Wang L; Yu Z; Yan Q; Guo Y; Guo S; Wei L; Shi M; Wang Z
    Diagn Pathol; 2015 Nov; 10():200. PubMed ID: 26537362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of parametrial invasion in women with early stage cervical cancer: a meta-analysis.
    Ma C; Zhang Y; Li R; Mao H; Liu P
    Arch Gynecol Obstet; 2018 Mar; 297(3):573-580. PubMed ID: 29177590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer.
    Widschwendter P; Janni W; Scholz C; De Gregorio A; De Gregorio N; Friedl TWP
    Arch Gynecol Obstet; 2019 Dec; 300(6):1709-1718. PubMed ID: 31696367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small FIGO stage IB cervical cancer.
    Girardi F; Burghardt E; Pickel H
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):427-32. PubMed ID: 7835783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis analysis of 83 cases of cervical adenosquamous carcinoma].
    Yan M; Zhang YN; He JH; Huang H
    Ai Zheng; 2008 Sep; 27(9):956-61. PubMed ID: 18799035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
    Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
    Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ib1-IIb cervical cancer.
    Li D; Cai J; Kuang Y; Cao J; Wang Z
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):802-9. PubMed ID: 22486458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.